Institutional members access full text with Ovid®

Activation of NOD2mediated intestinal pathway in a pediatric population with Crohn's disease

Negroni, Anna PhD1; Stronati, Laura PhD1; Pierdomenico, Maria PhD1; Tirindelli, Donatella MD1; Di Nardo, Giovanni MD2; Mancini, Valentina MD2; Maiella, Giulia MD2; Cucchiara, Salvatore MD, PhD2,*

doi: 10.1002/ibd.20907
Original Article

Background:: NOD2 is an intracellular protein involved in host recognition of specific bacterial molecules and is genetically associated with several inflammatory diseases, including Crohn's disease (CD). NOD2 stimulation activates the transcription factor, NF‐κB, through RIP2, a caspase‐recruitment domain‐containing kinase. NOD2/RIP2 signaling also mediates the activation of antimicrobial peptides such as human α‐defensin 5 (HD‐5) and human α‐defensin 6 (HD‐6), both produced by Paneth cells. The present study is aimed at describing the downstream events triggered specifically by NOD2 induction in order to demonstrate that the protein, other than overexpressed, is also physiologically associated with RIP2 and Erbin in the bioptic intestinal inflamed specimens of children affected by CD.

Methods:: Fifteen children with CD and 10 children used as controls were entered in the study. Mucosal biopsy specimens were taken during endoscopy and mRNA and protein expressions were detected by using real‐time polymerase chain reaction and Western blot.

Results:: NOD2 is able to form an immunocomplex with the kinase RIP2. As compared to controls, in the inflamed mucosa of patients both mRNA and protein expression levels of RIP2 are increased, and its active phosphorylated form is overexpressed.

Conclusions:: In this study we provide for the first time ex vivo evidence of physiologically relevant protein interactions with NOD2, which are able to trigger the innate immune response in intestinal mucosal specimens of children with CD.

(Inflamm Bowel Dis 2009)

1Section of Toxicology and Biomedical Sciences, Enea, Rome, Italy

2Paediatric Gastroenterology and Liver Unit, University of Rome, Sapienza University Hospital Umberto I, Rome, Italy

Received for publication December 28, 2008; Accepted January 23, 2009.

Supported by grants from Italian University Ministry, Research Projects of National Interest (PRIN) 2004065777.

*Department of Paediatrics, Paediatric Gastroenterology and Liver Unit, Head, University Hospital Umberto I ‐ Sapienza University of Rome, Viale Regina Elena 324 ‐ 00161 Rome, Italy (e‐mail: salvatore.cucchiara@uniroma1.it).

DOI 10.1002/ibd.20907

Published online 5 March 2009 in Wiley InterScience (www.interscience.wiley.com).

© Crohn's & Colitis Foundation of America, Inc.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website